<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04675164</url>
  </required_header>
  <id_info>
    <org_study_id>LAISS</org_study_id>
    <nct_id>NCT04675164</nct_id>
  </id_info>
  <brief_title>Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men</brief_title>
  <official_title>Outcome of ICSI Using Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the outcome of ICSI after using LAISS for selection of viable&#xD;
      immotile testicular sperm in azoospermic infertile men.&#xD;
&#xD;
      Patients will be randomly assigned to 2 groups. In (LAISS) group, viable immotile testicular&#xD;
      sperms will be selected before ICSI using laser assisted immotile sperm selection (study&#xD;
      group). In (HOST) group, viable immotile testicular sperms will be selected before ICSI using&#xD;
      hypo-osmotic swelling test (control group).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>(LAISS) group: viable immotile testicular sperms will be selected before ICSI using laser assisted immotile sperm selection (study group).&#xD;
(HOST) group: viable immotile testicular sperms will be selected before ICSI using hypo-osmotic swelling test (control group).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>With an online tool, participants will be randomized to undergo ICSI with HOST and LAISS sperm selection arms with a 1:1 allocation ratio as per a computer-generated list, using permuted block sizes of 8, and 16, stratified for sites and fresh or cryopreserved sperm. Results of allocation will be in sealed opaque envelopes labeled with unique random codes. Clinicians, embryologists, and participants in all centers will have no access to allocation results. Upon consent, instructors will assign participants to the relevant group. Embryologists who will perform fertilization check and embryo grading will be unaware of the sperm selection method. Women will undergo only day 5 blastocysts transfer. This trial will also conceal the allocation from participants and clinical team.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6- 7 weeks</time_frame>
    <description>Presence of a fetal heartbeat at 6-7 weeks of pregnancy.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Azoospermia</condition>
  <condition>IVF</condition>
  <arm_group>
    <arm_group_label>LAISS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Viable immotile testicular sperms will be selected before ICSI using laser assisted immotile sperm selection (study group).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HOST group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Viable immotile testicular sperms will be selected before ICSI using hypo-osmotic swelling test (control group).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Assisted Immotile Sperm Selection</intervention_name>
    <description>LAISS will be performed using diode laser system at the lowest working power with a single laser shot at the lower one third of the sperm tail. If sperm tail curling occurred, the sperm is then viable and will be utilized for ICSI after immobilization in PVP.</description>
    <arm_group_label>LAISS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypo-osmotic Swelling Test</intervention_name>
    <description>HOST will be performed by transferring immotile sperms from incubation droplet into HOST droplet, with any sperm showing tail swelling will be identified as viable and will be utilized for ICSI after immediate transfer and immobilization.</description>
    <arm_group_label>HOST group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible couples are those undergoing ICSI due to azoospermia with testicular biopsy&#xD;
             positive for sperm (either fresh or cryopreserved) following testicular sperm&#xD;
             extraction (TESE) or aspiration (TESA).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cases with female factor infertility or woman age above 35 years will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramadan SA Saleh, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sohag Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamad AH Mohamad, MSc</last_name>
    <phone>+201000146001</phone>
    <email>Mohammed.Suity@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ramadan SA Saleh, MD</last_name>
    <phone>01005423054</phone>
    <email>salehr2010@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ajyal Hospital, IVF Center</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramadan SA Saleh, MD</last_name>
      <phone>01005423054</phone>
      <email>salehr2010@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Mohamed Alaa El-Dein Hasan</investigator_full_name>
    <investigator_title>Assistant Lecturer of Dermatology, Venreology and Andrology</investigator_title>
  </responsible_party>
  <keyword>Laser Assisted Immotile Sperm Selection</keyword>
  <keyword>Hypo-osmotic swelling test</keyword>
  <keyword>ICSI</keyword>
  <keyword>Testicular sperm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Share IPD upon justified request to study director</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data shall become permanently available for share in Q3 2022.</ipd_time_frame>
    <ipd_access_criteria>Justified request to study director</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

